4186 Stock Overview
Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Taiwan Advance Bio-Pharmaceutical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$15.35 |
| 52 Week High | NT$20.90 |
| 52 Week Low | NT$14.00 |
| Beta | 0.85 |
| 11 Month Change | -3.46% |
| 3 Month Change | 0% |
| 1 Year Change | -11.78% |
| 33 Year Change | -22.28% |
| 5 Year Change | -22.83% |
| Change since IPO | -79.40% |
Recent News & Updates
Shareholder Returns
| 4186 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 0.3% | -0.5% | -2.4% |
| 1Y | -11.8% | 8.2% | 36.2% |
Return vs Industry: 4186 underperformed the TW Biotechs industry which returned 8.2% over the past year.
Return vs Market: 4186 underperformed the TW Market which returned 36.2% over the past year.
Price Volatility
| 4186 volatility | |
|---|---|
| 4186 Average Weekly Movement | 6.2% |
| Biotechs Industry Average Movement | 5.1% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in TW Market | 8.8% |
| 10% least volatile stocks in TW Market | 2.9% |
Stable Share Price: 4186 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 4186's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 154 | n/a | www.biotest.com.tw |
Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse.
Taiwan Advance Bio-Pharmaceutical Inc. Fundamentals Summary
| 4186 fundamental statistics | |
|---|---|
| Market cap | NT$1.38b |
| Earnings (TTM) | NT$21.41m |
| Revenue (TTM) | NT$338.83m |
64.5x
P/E Ratio4.1x
P/S RatioIs 4186 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4186 income statement (TTM) | |
|---|---|
| Revenue | NT$338.83m |
| Cost of Revenue | NT$109.66m |
| Gross Profit | NT$229.17m |
| Other Expenses | NT$207.77m |
| Earnings | NT$21.41m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.24 |
| Gross Margin | 67.64% |
| Net Profit Margin | 6.32% |
| Debt/Equity Ratio | 122.0% |
How did 4186 perform over the long term?
See historical performance and comparison